Biosimilars In Emerging Economies - Advanced Recombinant Technology Platforms And Low Cost Manufacturing Put India And China At A Strategic Advantage In Biosimilar Production

Table 16: Biosimilars in Emerging Economies, Pipeline Molecules, Lupin, 2012 39

Table 17: Biosimilars in Emerging Economies, Pipeline Molecules, Cipla, 2012 40

Table 18: Biosimilars in Emerging Economies, China, Revenue ($bn), 2002–2011 41

Table 19: Biosimilars in Emerging Economies, China, Revenue Forecasts ($bn), 2011–2018 41

Table 20: Biosimilars in Emerging Economies, Marketed Biosimilar Products, China, 2012 42

Table 21: Biosimilars in Emerging Economies, Marketed Biosimilar Products, 3SBio, 2012 43

Table 22: Biosimilars in Emerging Economies, Pipeline Molecules, 3SBio, 2012 44

Table 23: Biosimilars in Emerging Economies, Marketed Biosimilar Products, CPGJ, 2012 45

Table 24: Biosimilars in Emerging Economies, Pipeline Molecules, CPGJ, 2012 45

Table 25: Biosimilars in Emerging Economies, Marketed Biosimilar Products, Biotech Pharma, 2012 46

Table 26: Biosimilars in Emerging Economies, Pipeline Molecules, Filed, 2011 60

Table 27: Biosimilars in Emerging Economies, Pipeline Molecules, Phase III, 2011 60

Table 28: Biosimilars in Emerging Economies, Pipeline Molecules, Phase II, 2011 62

Table 29: Biosimilars in Emerging Economies, Pipeline Molecules, Phase I, 2011 62

Table 30: Biosimilars in Emerging Economies, Pipeline Molecules, Pre-clinical, 2011 63

Table 31: Biosimilars in Emerging Economies, Pipeline Molecules, Discovery, 2011 65

Table 32: Biosimilars in Emerging Economies, Pipeline Molecules, IND Filed, 2011 66

Table 33: Biosimilars in Emerging Economies, Pipeline Molecules, Unknown Phase, 2011 66

Table 34: Biosimilars in Emerging Economies, M&A by Year, 2007–2011 74

Table 35: Biosimilars in Emerging Economies, M&A by Value ($m), 2007–2011 75

Table 36: Biosimilars in Emerging Economies, M&A Deals, 2007–2011 76

Table 37: Biosimilars in Emerging Economies, Licensing Agreements, 2007–2011 78

Table 38: Biosimilars in Emerging Economies, Co-developments, 2007–2011 80

 

 

 

List of Figures

 

Figure 1: Biosimilars in Emerging Economies, EPO Biosimilars Marketed Outside the US and EU, 2011 12

Figure 2: Biosimilars in Emerging Economies, G-CSF Biosimilars Marketed Outside the US and EU, 2011 13

« First ‹ Previous 1 2 3 4 5 6 7 8 Next › Last »